Led · Seed · Feb 2026

Electric Twin, founded by Dr. Ben Warner and Alex Cooper in London, has built a platform that uses artificial intelligence, machine learning and social-science research to model how real customer segments behave. By generating synthetic audiences, the software enables enterprises to obtain feedback on products, messaging and marketing campaigns within minutes rather than weeks. Early adopters include The Times and mobile network operator Lebara, validating the product’s utility across media and telecom sectors. The company positions its technology as “the world’s most powerful prediction engine” and plans to accelerate global expansion while continuing product development. To date, Electric Twin has secured $14 million in external financing across pre-seed and seed rounds. Although detailed operating metrics such as revenue or user counts were not disclosed, the calibre of customers and investors underscores market traction. The recent capital infusion will primarily fund R&D and international go-to-market initiatives aimed at scaling the platform’s adoption.

Participated · Seed · Feb 2025

Level Zero Health develops DNA-based aptamer sensors and minimally invasive wearable patches to continuously and remotely monitor hormone levels. Its initial product is a camera-readable colourimetric patch, and it is developing a microneedle wearable that delivers real-time measurements of stress and reproductive hormones. The company is also building what it calls the world’s largest hormone health dataset and has validated its sensors in simulated samples across 98% of the human clinical range. It is initially targeting B2B clinical applications—including IVF, menopause care and testosterone replacement therapy—with potential B2C and pharma expansion. Level Zero has already assembled a pipeline of customers and says it will use recent funding for R&D, hiring in the UK and US, and to bring the product to market. The startup was founded over a year ago by Ula Rustamova and Irene Jia and emphasizes transforming hormone tracking into a clinical-grade data platform. Level Zero Health is building technology for continuous hormone monitoring that aims to uncover previously inaccessible hormonal data. The company says its work grew out of personal frustration and years of research, which produced a roadmap to access new physiological information. Its product is positioned to improve patient care for clinicians, advance personalised medicine, and empower individuals to make better daily choices. The team came together at Entrepreneur First and has received a joint investment from Entrepreneur First and SOSV HAX. Level Zero Health has just arrived at HAX in New Jersey and plans to continue building toward its vision while in the program. The company frames its mission as revolutionising metabolic health.

Participated · Seed · Oct 2024

Round provides an AI-powered finance automation platform that combines intelligence with financial infrastructure to automate tasks such as invoice approvals, payment execution, payroll funding and synchronization with ERPs. It recently launched two products, Agentic Workflow Builder, which converts natural-language workflow descriptions into continuously running automated processes, and Autonomous Payroll, which streamlines the payroll cycle from payslip import to payment execution. The company emphasizes automating repetitive operational finance tasks rather than replacing finance leaders. Round integrates with existing banks and accounting systems and has existing customers, about 10% of whom invested in the recent seed round. Proceeds from the $6M seed will be used to accelerate product development, hire across engineering and go-to-market, deepen integrations, scale infrastructure, and support community initiatives to drive adoption.

Participated · Seed · Sep 2023

Jude builds products and services focused on bladder health, initially targeting women. Its core offering is a non-prescription bladder-strength supplement (pumpkin seed extract and soy germ extract) sold alongside absorbent pants, liners and pads. Jude operates a free support hotline staffed by trained specialists, a pelvic-floor exercise plan and a 4,000-member community; it also has a medical board and some in-house GPs. The company launched in the U.K. in January last year and has reached about 18,000 customers so far, projecting 4x U.K. usage in 12 months and roughly 100,000 customers next year as it expands to the U.S. Jude plans a digital consultation service and is applying for a U.K. medical licence for its supplement while pursuing patents and further studies to deepen product defensibility. The team intends to add more medical expertise (urologists/doctors) over time and to broaden its digital proposition and research partnerships. Jude builds consumer bladder-care products including fully biodegradable, 100% plant-based liners and pads alongside clinically tested bladder-strength supplements. Launched in January 2022 by founder Peony Li, the platform aims to destigmatise bladder issues and create a community around incontinence. The company has already shipped products to 2,600 customers. Jude recently raised £2 million in a pre-seed round to fund growth. Planned uses of capital include R&D to further develop affordable bladder-care solutions, running large-scale clinical supplements trials, expanding the marketing team, and producing educational content to break down taboos. The company positions its supplements as clinically tested formulations using botanicals shown to improve bladder care and associated wellbeing.

Participated · Series A · Nov 2022

Vieve is a care and beauty company founded in 2020 by makeup artist Jamie Genevieve and led by Emma Dawson. The company develops beauty products formulated to be vegan, paraben-, gluten- and cruelty-free. Vieve raised £5.5M in a Series A funding round. Backers included Pembroke VCT (which contributed £1M), Venrex, Samos and Active Partners. The company intends to use the funds to expand the team, develop products and grow the brand globally, starting from the US and Australia. Vieve is based in Glasgow, Scotland.